Acrux Ltd has released a press release.
Monthly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Acrux
- Launch of 90 gram pack size of Dapsone 5%, Gel in US
- Acrux raises $1.34 million from SPP
- Investor Deck update, SPP Closes 18 December 2024, 5pm
- Commercialisation of Nitroglycerin Ointment
- Share Purchase Plan Offer Booklet
Later from Acrux
- Acrux CEO announces plan to retire
- Appendix 4D and December 2024 Half Year Accounts
- Investor Presentation February 2025
- Acrux receives $1.73m advance on FY25 R&D Tax Incentive
- Acrux CEO and Managing Director appointment
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux